$88.47
Revenue is up for the last 9 quarters, 627.25M → 886.84M (in $), with an average increase of 4.2% per quarter
Netprofit is down for the last 2 quarters, 60.47M → 59.85M (in $), with an average decrease of 1.0% per quarter
In the last 1 year, HCA Healthcare Inc has given 27.7% return, outperforming this stock by 14.3%
In the last 3 years, HCA Healthcare Inc has given 142.8% return, outperforming this stock by 37.3%
1.44%
Downside
Day's Volatility :2.22%
Upside
0.79%
20.76%
Downside
52 Weeks Volatility :31.45%
Upside
13.49%
Period | Ensign Group Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -2.07% | 0.7% | -6.8% |
6 Months | -6.08% | -8.3% | -6.0% |
1 Year | 13.4% | -1.9% | -4.6% |
3 Years | 105.54% | 25.3% | 25.9% |
Market Capitalization | 4.9B |
Book Value | $23.79 |
Dividend Share | 0.225 |
Dividend Yield | 0.26% |
Earnings Per Share (EPS) | 4.11 |
PE Ratio | 21.42 |
PEG Ratio | 1.31 |
Wall Street Target Price | 111.25 |
Profit Margin | 7.32% |
Operating Margin TTM | 9.46% |
Return On Assets TTM | 5.48% |
Return On Equity TTM | 19.61% |
Revenue TTM | 3.2B |
Revenue Per Share TTM | 58.11 |
Quarterly Revenue Growth YOY | 24.3% |
Gross Profit TTM | 534.9M |
EBITDA | 366.2M |
Diluted Eps TTM | 4.11 |
Quarterly Earnings Growth YOY | 0.18 |
EPS Estimate Current Year | 4.7 |
EPS Estimate Next Year | 5.12 |
EPS Estimate Current Quarter | 1.1 |
EPS Estimate Next Quarter | 1.15 |
What analysts predicted
Upside of 25.75%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 1.8B | ↑ 11.75% |
Net Income | 40.5M | ↓ 19.03% |
Net Profit Margin | 2.19% | ↓ 0.83% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↑ 10.35% |
Net Income | 92.4M | ↑ 128.2% |
Net Profit Margin | 4.53% | ↑ 2.34% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↓ 0.2% |
Net Income | 110.5M | ↑ 19.67% |
Net Profit Margin | 5.43% | ↑ 0.9% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↑ 17.98% |
Net Income | 170.5M | ↑ 54.23% |
Net Profit Margin | 7.1% | ↑ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↑ 9.36% |
Net Income | 194.7M | ↑ 14.18% |
Net Profit Margin | 7.41% | ↑ 0.31% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↑ 15.15% |
Net Income | 224.7M | ↑ 15.43% |
Net Profit Margin | 7.43% | ↑ 0.02% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 693.1M | ↑ 3.68% |
Net Income | 48.7M | ↑ 3.09% |
Net Profit Margin | 7.03% | ↓ 0.04% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 713.4M | ↑ 2.93% |
Net Income | 50.3M | ↑ 3.28% |
Net Profit Margin | 7.06% | ↑ 0.03% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 732.5M | ↑ 2.67% |
Net Income | 57.7M | ↑ 14.6% |
Net Profit Margin | 7.88% | ↑ 0.82% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 770.0M | ↑ 5.12% |
Net Income | 56.2M | ↓ 2.62% |
Net Profit Margin | 7.3% | ↓ 0.58% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 809.5M | ↑ 5.13% |
Net Income | 60.5M | ↑ 7.64% |
Net Profit Margin | 7.47% | ↑ 0.17% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 886.8M | ↑ 9.55% |
Net Income | 59.9M | ↓ 1.02% |
Net Profit Margin | 6.75% | ↓ 0.72% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↑ 10.13% |
Total Liabilities | 602.4M | ↑ 11.44% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 7.21% |
Total Liabilities | 579.6M | ↓ 3.78% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 99.83% |
Total Liabilities | 1.7B | ↑ 194.29% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↑ 7.78% |
Total Liabilities | 1.7B | ↑ 1.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 11.98% |
Total Liabilities | 1.8B | ↑ 5.88% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 3.5B | ↑ 21.1% |
Total Liabilities | 2.2B | ↑ 20.47% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 2.9B | ↑ 1.32% |
Total Liabilities | 1.8B | ↓ 0.28% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↑ 6.8% |
Total Liabilities | 2.0B | ↑ 7.85% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.1B | ↑ 2.63% |
Total Liabilities | 2.0B | ↑ 1.59% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.3B | ↑ 4.5% |
Total Liabilities | 2.1B | ↑ 3.97% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.5B | ↑ 5.72% |
Total Liabilities | 2.2B | ↑ 5.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.9B | ↑ 11.88% |
Total Liabilities | 2.5B | ↑ 15.4% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 73.0M | ↓ 1.27% |
Investing Cash Flow | -106.6M | ↓ 49.39% |
Financing Cash Flow | 18.3M | ↓ 88.05% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 210.3M | ↑ 188.27% |
Investing Cash Flow | -151.2M | ↑ 41.86% |
Financing Cash Flow | -70.3M | ↓ 484.99% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 192.2M | ↓ 8.6% |
Investing Cash Flow | -247.0M | ↑ 63.36% |
Financing Cash Flow | 82.9M | ↓ 217.83% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 373.4M | ↑ 94.23% |
Investing Cash Flow | -58.7M | ↓ 76.25% |
Financing Cash Flow | -137.3M | ↓ 265.65% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 275.7M | ↓ 26.16% |
Investing Cash Flow | -173.9M | ↑ 196.44% |
Financing Cash Flow | -76.1M | ↓ 44.55% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 272.5M | ↓ 1.15% |
Investing Cash Flow | -186.2M | ↑ 7.06% |
Financing Cash Flow | -32.3M | ↓ 57.63% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 71.2M | ↓ 25.91% |
Investing Cash Flow | -116.0M | ↑ 582.3% |
Financing Cash Flow | 2.4M | ↓ 91.06% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 45.9M | ↓ 35.57% |
Investing Cash Flow | -48.2M | ↓ 58.43% |
Financing Cash Flow | -11.3M | ↓ 565.72% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 83.9M | ↑ 82.98% |
Investing Cash Flow | -28.4M | ↓ 41.22% |
Financing Cash Flow | -18.5M | ↑ 64.31% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 92.5M | ↑ 10.23% |
Investing Cash Flow | -67.2M | ↑ 136.9% |
Financing Cash Flow | -2.1M | ↓ 88.87% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 50.2M | ↓ 45.77% |
Investing Cash Flow | -42.4M | ↓ 36.86% |
Financing Cash Flow | -359.0K | ↓ 82.62% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 48.3M | ↓ 3.65% |
Investing Cash Flow | -36.0M | ↓ 15.18% |
Financing Cash Flow | -1.7M | ↑ 366.3% |
Sell
Neutral
Buy
Ensign Group Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Ensign Group Inc | -8.88% | -6.08% | 13.4% | 105.54% | 157.9% |
![]() agilon health, Inc. | -18.19% | 10.08% | 9.35% | -35.87% | -35.87% |
![]() HCA Holdings, Inc. | -6.98% | 10.79% | 27.66% | 142.75% | 153.25% |
![]() Universal Health Services Inc. | -10.84% | 1.48% | 9.42% | 26.33% | 15.75% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Ensign Group Inc | 21.42 | 21.42 | 1.31 | 4.7 | 0.2 | 0.05 | 0.0 | 23.79 |
![]() agilon health, Inc. | NA | NA | NA | -0.11 | -0.08 | -0.04 | 0.0 | 2.61 |
![]() HCA Holdings, Inc. | 13.31 | 13.31 | 1.37 | 18.16 | 0.21 | 0.11 | 0.01 | -9.04 |
![]() Universal Health Services Inc. | 13.63 | 13.63 | 1.87 | 10.18 | 0.11 | 0.05 | 0.01 | 85.67 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Ensign Group Inc | Buy | $4.9B | 157.9% | 21.42 | 7.32% |
![]() agilon health, Inc. | Buy | $8.4B | -35.87% | NA | -2.88% |
![]() HCA Holdings, Inc. | Buy | $72.7B | 153.25% | 13.31 | 9.42% |
![]() Universal Health Services Inc. | Hold | $9.0B | 15.75% | 13.63 | 5.05% |
BlackRock Inc
Vanguard Group Inc
Wasatch Advisors Inc.
Fuller & Thaler Asset Management Inc
State Street Corporation
Riverbridge Partners LLC
In the quarter ending March,2023. Ensign Group Inc has declared dividend of $0.06
Read MoreThe Ensign Group independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 231 healthcare facilities, in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin.
Organization | Ensign Group Inc |
Employees | 29900 |
CEO | Mr. Barry R. Port |
Industry | Health Services |